Preclinical assessment of CNS drug action using eye movements in mice.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3163951)

Published in J Clin Invest on August 08, 2011

Authors

Hugh Cahill1, Amir Rattner, Jeremy Nathans

Author Affiliations

1: Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Articles cited by this

Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov (2004) 15.57

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell (1996) 12.59

Hazards of heavy metal contamination. Br Med Bull (2003) 7.51

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell (1994) 6.02

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov (2004) 4.31

Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science (2010) 3.60

A key role of starburst amacrine cells in originating retinal directional selectivity and optokinetic eye movement. Neuron (2001) 3.18

Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell (2009) 2.63

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol (2007) 2.57

Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet (2007) 2.54

Distinct roles of transcription factors brn3a and brn3b in controlling the development, morphology, and function of retinal ganglion cells. Neuron (2009) 1.95

Saccades in presymptomatic and early stages of Huntington disease. Neurology (2006) 1.92

Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat Rev Drug Discov (2007) 1.91

The accessory optic system. Annu Rev Neurosci (1984) 1.73

Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology (2005) 1.71

Loss of the neural integrator of the oculomotor system from brain stem lesions in monkey. J Neurophysiol (1987) 1.62

Invertebrate animal models of diseases as screening tools in drug discovery. ACS Chem Biol (2007) 1.51

Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol (2008) 1.47

The optokinetic reflex as a tool for quantitative analyses of nervous system function in mice: application to genetic and drug-induced variation. PLoS One (2008) 1.44

Neurobehavioral assessment in the information age. Nat Neurosci (2004) 1.41

Novel approach to the behavioural characterization of inbred mice: automated home cage observations. Genes Brain Behav (2006) 1.38

Pharmacological treatment effects on eye movement control. Brain Cogn (2008) 1.30

In need of high-throughput behavioral systems. Drug Discov Today (2002) 1.29

Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor. J Pharmacol Exp Ther (2000) 1.26

Impairment of pupillary responses and optokinetic nystagmus in the mGluR6-deficient mouse. Neuropharmacology (1997) 1.24

Chemistry-to-gene screens in Caenorhabditis elegans. Nat Rev Drug Discov (2005) 1.23

Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J Pharmacol Toxicol Methods (2008) 1.22

A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior. Psychopharmacology (Berl) (2007) 1.16

The role of blood-brain barrier studies in the pharmaceutical industry. Curr Drug Metab (2006) 1.08

Dynamic properties, interactions and adaptive modifications of vestibulo-ocular reflex and optokinetic response in mice. Neurosci Res (2001) 1.07

Using eye movements to assess brain function in mice. Vision Res (2004) 1.03

Specific oculomotor deficit after diazepam. II. Smooth pursuit eye movements. Psychopharmacology (Berl) (1981) 0.95

Mapping of a quantitative trait locus for morphine withdrawal severity. Mamm Genome (2004) 0.93

Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Prog Brain Res (2008) 0.93

Preclinical behavioral models for predicting antipsychotic activity. Adv Pharmacol (2009) 0.93

Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving. Curr Opin Pharmacol (2005) 0.91

Saccadic impairments in Huntington's disease. Exp Brain Res (2008) 0.89

Biomarkers for the effects of antipsychotic drugs in healthy volunteers. Br J Clin Pharmacol (2001) 0.87

Neurotoxic effect of lead at low concentrations. Brain Res Bull (2001) 0.84

A novel method for automatic quantification of psychostimulant-evoked route-tracing stereotypy: application to Mus musculus. Psychopharmacology (Berl) (2007) 0.84

Test-retest reliability of saccadic measures in subjects at risk for Huntington disease. Invest Ophthalmol Vis Sci (2009) 0.84

Specific oculomotor deficit after acute methadone. II. Smooth pursuit eye movements. Psychopharmacology (Berl) (1980) 0.80

Dynamic characteristics and adaptability of reflex eye movements of Fyn-kinase-deficient mice. Neurosci Lett (2000) 0.80

Eye-tracking dysfunction in the affective psychoses and schizophrenia. Psychol Med (1992) 0.78

Quantitative eye tracking tests in lead workers. Am J Ind Med (1980) 0.77

Neuro-ophthalmological signs during rapid intravenous administration of phenytoin. J Clin Neurosci (1999) 0.77

Smooth pursuit eye movements among storage battery workers. Clin Toxicol (1981) 0.76

Articles by these authors

Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell (2004) 5.04

Anterior-posterior guidance of commissural axons by Wnt-frizzled signaling. Science (2003) 4.18

The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A (2002) 3.73

Tissue/planar cell polarity in vertebrates: new insights and new questions. Development (2007) 3.66

The role of Frizzled3 and Frizzled6 in neural tube closure and in the planar polarity of inner-ear sensory hair cells. J Neurosci (2006) 3.36

A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J Neurosci (2003) 3.26

Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell (2009) 2.63

Frizzled6 controls hair patterning in mice. Proc Natl Acad Sci U S A (2004) 2.54

Quantitative analysis of neuronal morphologies in the mouse retina visualized by using a genetically directed reporter. J Comp Neurol (2004) 2.47

Emergence of novel color vision in mice engineered to express a human cone photopigment. Science (2007) 2.41

Structure-function analysis of the bestrophin family of anion channels. J Biol Chem (2003) 2.30

The rod photoreceptor-specific nuclear receptor Nr2e3 represses transcription of multiple cone-specific genes. J Neurosci (2005) 2.25

Frizzled-3 is required for the development of major fiber tracts in the rostral CNS. J Neurosci (2002) 2.23

Macular degeneration: recent advances and therapeutic opportunities. Nat Rev Neurosci (2006) 2.05

An MRI-based atlas and database of the developing mouse brain. Neuroimage (2010) 1.99

Distinct roles of transcription factors brn3a and brn3b in controlling the development, morphology, and function of retinal ganglion cells. Neuron (2009) 1.95

The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia. J Neurosci (2005) 1.81

Axonal growth and guidance defects in Frizzled3 knock-out mice: a comparison of diffusion tensor magnetic resonance imaging, neurofilament staining, and genetically directed cell labeling. J Neurosci (2006) 1.64

Genetically-directed, cell type-specific sparse labeling for the analysis of neuronal morphology. PLoS One (2008) 1.63

Role of a locus control region in the mutually exclusive expression of human red and green cone pigment genes. Proc Natl Acad Sci U S A (2002) 1.59

Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell (2012) 1.54

Mutational analysis of Norrin-Frizzled4 recognition. J Biol Chem (2006) 1.48

The optokinetic reflex as a tool for quantitative analyses of nervous system function in mice: application to genetic and drug-induced variation. PLoS One (2008) 1.44

Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function. Neuron (2011) 1.39

The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol Med (2010) 1.38

Order from disorder: Self-organization in mammalian hair patterning. Proc Natl Acad Sci U S A (2006) 1.37

Genetically engineered mice with an additional class of cone photoreceptors: implications for the evolution of color vision. Proc Natl Acad Sci U S A (2003) 1.30

New mouse lines for the analysis of neuronal morphology using CreER(T)/loxP-directed sparse labeling. PLoS One (2009) 1.28

Canonical WNT signaling components in vascular development and barrier formation. J Clin Invest (2014) 1.27

Estrogen-related receptor beta/NR3B2 controls epithelial cell fate and endolymph production by the stria vascularis. Dev Cell (2007) 1.27

Frizzled 1 and frizzled 2 genes function in palate, ventricular septum and neural tube closure: general implications for tissue fusion processes. Development (2010) 1.26

Effects of L1 retrotransposon insertion on transcript processing, localization and accumulation: lessons from the retinal degeneration 7 mouse and implications for the genomic ecology of L1 elements. Hum Mol Genet (2006) 1.20

Frizzled 2 and frizzled 7 function redundantly in convergent extension and closure of the ventricular septum and palate: evidence for a network of interacting genes. Development (2012) 1.19

Ca2+-activated Cl- current from human bestrophin-4 in excised membrane patches. J Gen Physiol (2006) 1.13

An essential role for frizzled 5 in mammalian ocular development. Development (2008) 1.11

An outer segment localization signal at the C terminus of the photoreceptor-specific retinol dehydrogenase. J Neurosci (2004) 1.11

Morphologies of mouse retinal ganglion cells expressing transcription factors Brn3a, Brn3b, and Brn3c: analysis of wild type and mutant cells using genetically-directed sparse labeling. Vision Res (2010) 1.10

The genomic response of the retinal pigment epithelium to light damage and retinal detachment. J Neurosci (2008) 1.09

An essential role for Frizzled5 in neuronal survival in the parafascicular nucleus of the thalamus. J Neurosci (2008) 1.07

Proteolytic shedding of the extracellular domain of photoreceptor cadherin. Implications for outer segment assembly. J Biol Chem (2004) 1.07

Genetic ablation of cone photoreceptors eliminates retinal folds in the retinal degeneration 7 (rd7) mouse. Invest Ophthalmol Vis Sci (2007) 1.07

When whorls collide: the development of hair patterns in frizzled 6 mutant mice. Development (2010) 1.06

Morphologic diversity of cutaneous sensory afferents revealed by genetically directed sparse labeling. Elife (2012) 1.05

Combinatorial expression of Brn3 transcription factors in somatosensory neurons: genetic and morphologic analysis. J Neurosci (2012) 1.05

Injury-independent induction of reactive gliosis in retina by loss of function of the LIM homeodomain transcription factor Lhx2. Proc Natl Acad Sci U S A (2012) 1.00

Expression of the Norrie disease gene (Ndp) in developing and adult mouse eye, ear, and brain. Gene Expr Patterns (2010) 1.00

A strabismus susceptibility locus on chromosome 7p. Proc Natl Acad Sci U S A (2003) 0.97

Genetic mosaic analysis reveals a major role for frizzled 4 and frizzled 8 in controlling ureteric growth in the developing kidney. Development (2011) 0.96

Frizzled3 controls axonal development in distinct populations of cranial and spinal motor neurons. Elife (2013) 0.96

Proximal and distal sequences control UV cone pigment gene expression in transgenic zebrafish. J Biol Chem (2004) 0.96

Responses of hair follicle-associated structures to loss of planar cell polarity signaling. Proc Natl Acad Sci U S A (2013) 0.93

Endothelin-2 signaling in the neural retina promotes the endothelial tip cell state and inhibits angiogenesis. Proc Natl Acad Sci U S A (2013) 0.91

Signaling by sensory receptors. Cold Spring Harb Perspect Biol (2012) 0.90

The evolution of Primate color vision. Sci Am (2009) 0.86

Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. J Clin Invest (2013) 0.82

How to draw the line in biomedical research. Elife (2013) 0.77

An evolutionary perspective on the photoreceptor damage response. Am J Ophthalmol (2006) 0.76

China's plan flawed but courageous. Science (2010) 0.75

Written in our genes? Science (2005) 0.75

THE CELLULAR COMPASS. Sci Am (2016) 0.75

Reck and Gpr124 Are Essential Receptor Cofactors for Wnt7a/Wnt7b-Specific Signaling in Mammalian CNS Angiogenesis and Blood-Brain Barrier Regulation. Neuron (2017) 0.75